MAPT and Alzheimer disease: Changes in plasma p-tau levels have been observed in several neurological disorders other than AD, including corticobasal syndrome,20 amyotrophic lateral sclerosis,21 and other conditions such as epilepsy,22 and traumatic encephalopathy syndrome.23